1327 Novel GCN2 modulator HC-7366 decreases pulmonary metastases and reduces myeloid-derived suppressor cellsJeremy Drees, Nandita Bose, Feven Tameire et al.|Regular and Young Investigator Award Abstracts|2022Cited by 5
Abstract 6231: Activation of GCN2 by HC-7366 results in significant antitumor efficacy as monotherapy and in combination with multiple standard of care agents in various solid cancer modelsFeven Tameire, Nandita Bose, Eric S. Lightcap et al.|Cancer Research|2023Cited by 3